Psoriasin In-ShowerTreatment

Coal Tar 2% (from Coal Tar Topical Solution, USP 20%)

Psoriasis / Seborrheic Dermatitis Treatment

For the relief of symptoms of psoriasis and/or seborrheic dermatitis including itching, scaling, flaking, redness and irriation of the skin. Helps prevent recurrence.

For external use only.

• for prolonged periods
• if condition covers a large area of the body
• with other forms of psoriasis therapy such as ultraviolet radiation or prescription drugs

avoid contact with the eyes. If contact occurs rinse thoroughly with water.

• condition worsens
• condition does not improve after regular use of this product as directed.

in exposing skin to sunlight after applying this product, as it may increase your tendency to sunburn for up to 24 hours after application.

Warning: This product contains chemicals known to the State of California to cause cancer.

If swallowed, get medical help or contact a poison control cente right away.

After cleansing, apply Psoriasin In-Shower Treatment to affected areas on body and scalp. Avoid applying to bottom of feet. Leave on for at least 2 minutes, then rinse off and gently towel dry. For best results, use at least twice a week or as directed by a doctor. The active ingredient, coal tar, in Psoriasin may affect very light hair color; test first on a few strands of hair before broader application to areas where light-colored hair is present. For use by normally healthy adults only; persons under 18 years of age or those with highly sensitive or allergic skin should use only as idrected by a doctor.

You may report serious side effects to the phone number provided under Questions? below.

Aloe vera gel, capylic/capric triglycerides, cetearyl alcohol, citric acid anhydrous, Dead Sea salts, ethanol, glycerin, glyceryl stearate SE, lavender oil, myristyl alcohol, oatmeal extract, olive oil, PEG-100 stearate, petrolatum, phenoxyethanol, polysorbate 80, shea oil, stearyl alcohol, sweet almond oil, water.

1-800-792-2582

[Image in the official label — see DailyMed source]